Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/86447

Download in:

View as

Triples

General Info

PMID
86447